Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th
-
Eala-conqueror Wang wins Asian Games tennis gold and Olympic berth
-
Tom Kim leads Asian Games golf in chase to avoid military service
-
'Kinda cool' Raygun made breakdancing famous, Asian Games B-girls say
-
Asian stocks hit as oil spike fans rate hike bets, eyes on US jobs
-
Taiwan gender-row boxer Lin Yu-ting wins 'monumental' Asian Games gold
-
'We're losing our scientists': west Africa's STEM struggle
-
Taiwan receives its first US-made F-16V fighter jets
-
World powers gather in Pacific to chart climate battle
-
Lula, Bolsonaro trade scandal fire in final scramble for votes
-
Return of swarming moth spectacle has Australia in a flutter
-
Not-so-brave new world: virtual taekwondo makes Asian Games debut
-
Browns snuff out Rodgers fightback to beat Steelers 27-24
-
Arab Israeli candidate drops out of election race
-
Braves power past Phillies to set up Dodgers showdown
-
Israel courts Europe's far right, finding friends but also unease
-
Asian stocks drop as oil spike fans rate hike bets, eyes on US jobs
-
Lula, Bolsonaro both snub final debate before Brazil election
-
Viral anti-vax posts weaponise Philippine inoculation fears
-
Nepal's grim DNA puzzle to identify flood dead
-
Saudi coalition accuses Houthis of drone attack on Medina
-
EU nations to hold emergency meeting on soaring diesel prices amid US pressure
-
Effective Altruism: the philosophy behind Silicon Valley's AI fears
-
Anthropic's Dario Amodei: AI's most visible CEO and enigma
-
Chinese judoka accused of biting as home hope wins Asian Games gold
-
OpenAI says three staffers fired for mishandling 'sensitive' info
-
Four-member crew docks at International Space Station
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - October 02
-
Nike plans job cuts as it forecasts lower sales
-
Portugal win without Ronaldo as Klopp's Germany get first victory
-
Ireland game interrupted twice by Gaza protests
-
Wemby: 'Very sad' to see players endorse betting firms
-
Judge denies acquittal bid by US woman who killed her kids
-
Manchester City Women scrape draw with Real Madrid
-
Klopp averts crisis with first win as Germany boss
-
India, Australia and Pakistan in same World Cup group
-
A saintly spat and debate snub: Brazil enters final campaign stretch
-
Daryz's hopes of repeat Arc win boosted by draw
-
US tells European allies to act 'immediately' to lower diesel prices
-
Steelers ship disgruntled defender Porter to Cowboys
-
G20 trade ministers fail to see consensus against overproduction
-
Klopp gets first win as Germany boss
-
Portugal edge Denmark in Ronaldo's absence
-
Bolivia's attorney general arrested on drugs, money laundering charges
-
US stocks edge higher as bond yields retreat for now
-
Raiders host Chiefs in battle of unbeaten division rivals
-
US tells European allies to 'immediately' act to lower diesel prices
-
Lowest Fee Bitcoin ATMs Announces Launch of More Than 400 ATMs Nationwide
-
Trump vows to hit Iran 'very hard' if linked to flydubai attack
-
G20 against 'weaponization' of food trade: French minister
-
Williams leaves Spain camp with thigh knock
Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th
ESTERO, FL / ACCESS Newswire / August 13, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), today announced that management will be present and host one-on-one meetings with investors at Sidoti & Company's Micro-Cap Virtual Investor Conference taking place on August 19-20, 2026.
Management plans to discuss its clinical and commercial development pipeline and its recently closed acquisition of Dura Driver Control Systems, a leading global automotive supplier with a 100+ year history and $200M+ in 2025 revenue.
Sidoti Micro-Cap Virtual Conference Presentation Details
Dates: August 19-20, 2026
Date and Time: Wednesday, August 19, 2026, at 1:45 P.M. ET
Webcast: https://sidoti.zoom.us/webinar/register/WN_udxBu7lMQ9iYsAS6ydaFVA
One-on-One Meetings
Inspire will also host virtual one-on-ones with investors on Wednesday, August 19 and Thursday, August 20, 2026. To register for the presentation or one-on ones, visit https://sidoti.com/events.
About Aspire Biopharma Holdings, Inc.
Aspire Biopharma has developed a patent-pending sublingual delivery technology that can deliver drugs to the body rapidly and precisely. This technology offers the potential to improve effectiveness and reduce side effects by going directly to the bloodstream and avoiding the gastrointestinal tract. Aspire Biopharma's delivery technology can be applied to many different active pharmaceutical ingredients (APIs) and other bioactive substances.
Aspire's subsidiary Dura Driver Control Systems is a leading designer and manufacturer of highly engineered automotive and industrial systems that facilitate electronic driver control and support migration toward vehicle electrification, safety, lightweighting, and sustainability. DCS maintains a strong powertrain agnostic product portfolio that includes mechatronic actuators, human machine interfaces, industrial cables, and cable control systems backed by over 310 patents. The Company operates 11 manufacturing facilities globally and serves as a tier one automotive supplier to major OEMs and other industrial firms.
For more information, please visit www.aspirebiolabs.com
Aspire Biopharma Holdings, Inc.
Contact:
PCG Advisory
Kevin McGrath
+1-646-418-7002
[email protected]
SOURCE: Aspire Biopharma Holdings, Inc.
View the original press release on ACCESS Newswire
A.Rodriguezv--AMWN
